Common Stock, Shares, Outstanding of Stoke Therapeutics, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Stoke Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Stoke Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 55,120,002, a 4.1% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Stoke Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 55,120,002 +2,178,811 +4.1% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 54,723,455 +2,417,814 +4.6% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 54,595,714 +8,097,637 +17% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 54,032,826 +8,114,593 +18% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 52,941,191 +8,648,076 +20% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 52,305,641 +8,102,644 +18% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 46,498,077 +2,322,988 +5.3% 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 45,918,233 +6,478,658 +16% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 44,293,115 +4,866,675 +12% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 44,202,997 +4,820,530 +12% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 44,175,089 +5,130,420 +13% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 39,439,575 +2,537,076 +6.9% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q3 2022 39,426,440 +2,646,047 +7.2% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 39,382,467 +2,659,798 +7.2% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 39,044,669 +2,346,861 +6.4% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 36,902,499 +325,350 +0.89% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q3 2021 36,780,393 +3,419,205 +10% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 36,722,669 +3,510,125 +11% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 36,697,808 +3,730,458 +11% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 36,577,149 +3,715,307 +11% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 33,361,188 +637,035 +1.9% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 33,212,544 +537,979 +1.6% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 32,967,350 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 32,861,842 +32,134,429 +4418% 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q3 2019 32,724,153 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 32,674,565 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q4 2018 727,413 31 Dec 2018 10-K 23 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.